Compare Dolby Laboratories, Inc. (DLB) vs Vital Farms Inc (VITL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dolby Laboratories, Inc. vs Vital Farms Inc — how do they compare? Dolby Laboratories, Inc. trades at $61.9 (market cap $5.82B), while Vital Farms Inc trades at $11.57 (market cap $483.84M). The key difference: Dolby Laboratories, Inc. is far larger — about 12× Vital Farms Inc's market cap, and Dolby Laboratories, Inc. pays a 2.32% dividend while Vital Farms Inc pays none. Which is the better fit depends on your goals.
| DLB | VITL | |
|---|---|---|
Market Cap | $5.82B | $483.84M |
Sector | Industrials | Consumer Staples |
52-Week High | $75.62 | $52.41 |
52-Week Low | $48.51 | $8.28 |
Enterprise Value | $5.19B | $570.85M |
Dividend Yield | 2.32% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dolby Laboratories (DLB) trades at $61.77, up 1.4% today, with a bullish technical trend and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, including Q2 2026 EPS of $0.69 versus $0.67 expected. Revenue remains stable around $1.3 billion annually, with robust gross margins of 87.61%. Recent news highlights growth in Dolby Atmos and automotive licensing, though near-term revenue volatility persists.
DLB offers a compelling valuation with a P/E of 26.29 below the analyst target of $87.50, implying significant upside. Key risks include licensing deal timing and competitive pressures in audio-video tech. Institutional sentiment is positive, with 47% of analysts rating it a Buy, but investors should monitor execution on Q4 growth guidance.
Vital Farms (VITL) trades at $12.24, down 2.16% amid bearish technical signals and challenging Q2 2026 results with a net loss of $0.47 per share. Revenue declined 10.1% year-over-year to $166 million due to industry oversupply and competitive pressures. The company secured $125 million in term loan financing in August 2026 to support operations. Analyst consensus remains positive with a $13.00 price target and 56% buy ratings, though profitability metrics show significant compression with net income margin at 0.02%.
The stock faces near-term headwinds from operational challenges but maintains analyst support. Investment opportunity exists if the company can navigate industry oversupply and restore profitability. Key risks include persistent margin pressure, competitive pricing gaps, and execution of the new financing strategy. The current valuation at 11.77 P/E appears reasonable if earnings recovery materializes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →About Vital Farms Inc
Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →
